Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 24Phase 1 13Phase 1/2 8Phase 2/3 2Phase 4 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Ovarian Neoplasms 3Fallopian Tube Neoplasms 3Small Cell Lung Carcinoma 2Retinoblastoma 1Cystadenocarcinoma, Serous 1Carcinoma, Ovarian Epithelial 1

Interventions

Topotecan 2Drug Therapy 2sintilimab 1dinutuximab 1atezolizumab 1Temozolomide 1SR 48692 1Rabeprazole 1Irinotecan 1Etoposide 1Electroporation 1EC regimen 1E-3810 1Cryosurgery 1Carboplatin 1Bevacizumab 12,2',4,4',5-pentachlorodiphenyl ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Small Cell Lung Carcinoma × Topotecan × Clear all
NCT07106528 2025-08-06

Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer

Peking Union Medical College Hospital

Phase 2/3 Not yet recruiting
128 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03098030 2020-12-09

Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer

United Therapeutics

Phase 2/3 Completed
483 enrolled 19 charts
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡